期刊文献+

Chk1反义寡核苷酸影响胶质瘤放疗敏感性的研究 被引量:1

Transfection of Chk1 Antisense Oligonucleotide to Glioma Increases the Apoptotic Sensitivity to Irradiation
下载PDF
导出
摘要 目的:观察转染Chk1反义寡核苷酸(ASON)后,对照射后U251细胞株中Chk1表达、细胞周期及细胞凋亡的影响。方法:采用脂质体转染法,Chkl的正义、反义寡核苷酸对U251细胞株进行Chkl转染。以放射线照射后,测定其细胞周期和凋亡率变化,比较Chkl转染正义链和反义链对细胞放射敏感性的不同。用WesternBlot法检测Chk1蛋白,RealtimePCR检测Chk1mRNA表达。结果:转染Chk1反义寡核苷酸后,能明显下调Chk1蛋白和mRNA的表达,显著增强放射线诱导的肿瘤细胞凋亡,并消除细胞周期阻滞。结论:反义核酸技术灭活Chk1基因显著增强放疗诱导的U251细胞凋亡,为增敏胶质瘤的放射治疗提供了理论依据。 Objective :Effect on expression of Chkl and changes of cell cycle after radiation in U251 cell line with antisense oligodeoxynucleotide (ASON) were observed.Methods :The U251 cell line was transfected with Chkl sense and antisense chain-lipofectamine PLUS complex. Then irradiated it and measured the changes of the cell cycle and apoptosis in order to compare the diference between the Chkl sense and antisense chain. The expression of Chkl was measured by Western blot, and Chkl mRNA was measured by real time PCR.Results :The expression of Chkl protein and mRNA markedly decreased after ransfecting U251 cell line with Chkl antisense oligonucleotide.Transfecting U251 cell line with Chkl antisense oligonucleotide could increase apoptosis significantly and decrease cell cycle arrest markedly induced by irradiation.Conclusion :The sensitivity to apoptosis is excessively increased after treated with irradiation by transfection of Chkl antisense oligonucleotide to glioma. This can be the theoretical basis for increasing the apoptotic sensitivity to irradiation of glioma.
出处 《中国医学创新》 CAS 2012年第13期3-5,共3页 Medical Innovation of China
关键词 胶质瘤 细胞周期检测点激酶 反义寡核苷酸 放射敏感性 Glioma Checkpoint kinase Antisense oligonucleotide Irradiation
  • 相关文献

参考文献10

  • 1Cortez D,Guntuku S,Qin J,et al.ATR and ATRIP:partners in checkpoint signaling[J].Science,2001:294(5547):1713-1716.
  • 2Chen Y H,Sanchez Y.CHK1in the DNA damage response:conserved roles from yeasts to mammals[J].DNA Repair,2004,3(8):1025-1032.
  • 3Crooke S T.Progression in antisense technology:the end of the beginning[J].Methods Enzymol,2000:313(3):33-45.
  • 4Shapiro G,Kaelin J W.Anticancer drug targets:cell cycle and checkpoint control[J].J Clin Invest,1999:104(4):1645.
  • 5Sugimoto K,Sasaki M,Isobe Y,et al.Hsp90-inhibitor geldanamycin abrogates G2arrest in p53-negative leukemia cell lines through the depletion of Chk1[J].Oncogene,2008,27(22):3091-3101.
  • 6Yan Y,Black C,Cowan K.Irradiation-induced G2/M checkpoint response requires ERK1/2activation[J].Oncogene,2007,26(32):4689-4698.
  • 7Bourke E,Brown J,Takeda S,et al.DNA damage induces Chk1-dependent threonine-160phosphorylation and activation of Cdk2[J].Oncogene,2010,29(4):616-624.
  • 8Choi S,Lyu S,Park W.Mistletoe lectin induces apoptosis and telomerase inhibition in human A253cancer cells through dephosphorylation of akt[J].Archives of Pharmacal Research,2004,27(1):68-76.
  • 9Wraight C J,White P J.Antisense oligonucleotides in cutaneous therapy[J].Pharmacolopy&Therapeutics,2001,90(1),89-104.
  • 10Hirose Y,Berger M S,Pieper R O,et al.Abrogation of the Chk1-mediated G2checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human gliblastoma cells[J].Caner Res,2001,61(15):5843-5849.

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部